We also observed that IMQ treatment promoted the phosphorylation of ERK1/2 and Akt in BCC and SCC12 cells, indicating that the MAPK/ERK and Akt/mTOR signaling pathways were activated (Fig. 3E and Fig. S3B). This evidence concerns the gene MAPK3 and skin basal cell carcinoma.